Skip to main content
. 2024 Dec 23;15:1508423. doi: 10.3389/fmicb.2024.1508423

Table 2.

Laboratory and clinical characteristics of ICU and IDU patients.

Laboratory parameters IDU patients (n = 18) ICU patients (n = 17) p-value
Lymphocyte count (cells/mm3) 0.8 ± 0.17 0.66 ± 0.21 <0.01
LDH (U/L) 431 ± 232 926 ± 476 <0.001
D-dimer (ng/ml) 1,027 (228, 24,582) 1,597 (681, 329,800) NS
Ferritin (ng/ml) 1,035 (42, 6,155) 1,117 (32, 9,667) NS
CRP (mg/dl) 9.6 ± 6.7 12.8 ± 7.7 NS
IL-6 (pg/ml) 62 (7, 143) 61 (31, 924) NS
Clinical parameters
Days of hospitalization 8 ± 5 15 ± 12 <0.05
Mortality (n, %) 0 11 (64.7%)
SOFA 2 (0.4) 3 (0, 9) <0.05
SAPS 33 (13, 71)
CT score 11 ± 4.8 15 ± 6.8 <0.05
PaO2/FiO2 on admission 194 (32, 410) 67 (43, 388) <0.05
Mechanical ventilation (days) 4 (0, 19)
Kidney replacement therapy (n, %) 3 (17%)
Vasopressor therapy (n, %) 13 (76%)

Data are presented as mean ± standard deviation or median (minimum, maximum). Differences were considered significant when the P value was equal to or less than 0.05. ICU, Intensive care unit; IDU, infectious disease unit; HC, healthy control; LDH, lactate dehydrogenase; CRP, C-reactive protein; IL-6, interleukin-6; SOFA, Sequential organ failure assessment score; SAPS, simplified acute physiology score; CT score, computed tomography score; NS, not significant. Significant results are presented in bold.